The survey, which was commissioned by pharmaceutical company Biogen Idec, investigated the experiences of people with MS in Canada, France, Germany, Spain, Sweden and the United Kingdom. More than 400 people with MS and 180 healthcare professionals were surveyed.
The findings are supported by two recent pieces of research which have shown that walking ability is insufficiently monitored in people with MS by healthcare professionals and that 39% of people with MS and 49% of care partners never or rarely discuss mobility issues with a physician.
In addition, the survey underscored the impact of mobility impairment on employment and the social lives of people with MS. Of those surveyed: CLICK to Continue
***********************************************************